Activity profile in multiple sclerosis: an integrative approach. A preliminary report

Area of Science:

• Neuroimmunology
• Clinical Immunology
• Biomarker Discovery

Background:

• Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Understanding immune activity profiles is crucial for diagnosing and managing MS.
• Current methods may not fully capture the dynamic immune response in MS patients.

Purpose of the Study:

• To define an activity profile in multiple sclerosis (MS) patients by simultaneously assessing immune parameters.
• To identify potential biomarkers for disease activity and progression.
• To evaluate the utility of these markers for diagnosis and therapeutic monitoring.

Main Methods:

• Simultaneous assessment of T-cell subpopulations (CD4/CD45RA+, CD4/45R0+), proliferative responses to myelin basic protein (MBP), anti-MBP antibodies, nitrotyrosine levels, and serum CD40L (sCD154).
• Analysis was conducted in 29 consecutive, untreated MS patients across different disease stages (SP/I, RR/I, SP/A, RR/A) and compared to controls.
• Measurements included serum and cerebrospinal fluid (CSF) analysis.

Main Results:

• MS patients showed a significant decrease in CD4/CD45RA+ T cells and an increase in CD4/45R0+ T cells compared to controls.
• Elevated in vitro T-cell proliferative responses to MBP, increased serum CD40L (sCD154) levels, and higher CSF and serum levels of anti-MBP antibodies and nitrotyrosine were observed in active MS stages.
• These changes were statistically significant (p < 0.001) across various patient groups.

Conclusions:

• Simultaneous evaluation of immune and inflammatory markers provides an integrative approach to characterize MS clinical activity.
• These markers can aid in initial diagnosis and monitoring during disease recurrences.
• This approach helps determine if immune-mediated nerve destruction mechanisms are active, even with minimal clinical findings.